Form 4: Edwards Lifesciences CFO Scott Ullem Executes Stock Option and Sells Shares Under 10b5-1 Plan

Edwards Lifesciences' CFO, Scott Ullem, exercised stock options and sold shares on May 21, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 21, 2024, Scott B. Ullem, the CVP and Chief Financial Officer of Edwards Lifesciences Corp, executed a transaction involving the company's stock.
• Ullem exercised employee stock options to acquire 5,625 shares of common stock at a price of $45.2767 per share.
• Simultaneously, Ullem sold 5,625 shares of common stock at a weighted average price of $90.4539, with individual sales prices ranging from $90.225 to $90.720.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 15, 2024.
• Following these transactions, Ullem directly owns 30,561 shares and indirectly owns 266,318 shares through a trust, as well as 61,875 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine transactions under a pre-arranged trading plan. There's no indication of positive or negative implications for the company's performance.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to trade company stock.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan suggests a proactive approach to compliance with insider trading regulations.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in the financial industry to ensure fair market practices.
• Companies like Medtronic, Abbott, and Boston Scientific are also subject to similar regulations regarding insider trading and reporting.
• The use of 10b5-1 trading plans is a standard method employed by executives at these and other publicly traded companies to manage their stock transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates